St Bartholomew's Hospital — Barts Cancer Centre, London

Zusammenfassung

Barts Cancer Centre combines cancer care at a historic London hospital with research links to Barts Cancer Institute, part of Queen Mary University of London. Its areas of focus include haemato-oncology and cardio-oncology, alongside services for several common and rare solid tumours. Care may involve different specialties and locations across the wider hospital network, so patients should not assume every procedure takes place at St Bartholomew's. An indicative figure of around 150 active oncology clinical trials describes the supplied profile, rather than a verified current count of studies recruiting patients. International patients should obtain a records-based assessment, clarify NHS eligibility or private funding, and agree a practical plan for treatment and follow-up.

Das Wichtigste

The centre is part of Barts Health NHS Trust in London.
Its specialist programmes include blood, breast, lung, prostate and rare cancers.
Treatment recommendations depend on diagnosis, stage, biomarkers and general health.
Research links include Barts Cancer Institute at Queen Mary University of London.
The figure of around 150 active oncology trials is indicative, not a current recruitment guarantee.
Overseas patients should confirm acceptance, funding and treatment sites before travelling.

Überblick

St Bartholomew's Hospital was founded in 1123 and is one of Europe's oldest hospitals. Its dedicated cancer centre forms part of a modern specialist hospital within Barts Health NHS Trust. The hospital's history is relevant background, but does not itself indicate whether a particular treatment is suitable for an individual patient.

The centre sits within a large NHS hospital network serving London and receiving specialist referrals. Cancer care is organised through multidisciplinary teams that bring together expertise in diagnosis, oncology, surgery, imaging, pathology and supportive care. The combination of professionals involved varies according to the cancer type and proposed treatment.

Barts Cancer Institute provides an important research connection through Queen Mary University of London. Research and clinical services are related but distinct: an institute research programme does not necessarily represent an available treatment or an open clinical trial. Haemato-oncology and cardio-oncology are notable areas of the centre's profile. Private patient services provide a potential route for overseas care, subject to confirmation of the relevant service and funding arrangements.

Schwerpunkte

Blood cancers are a prominent part of the centre's profile, including conditions such as leukaemia, lymphoma and myeloma. Haemato-oncology assessment considers the precise disease subtype, laboratory findings, previous treatment and the patient's overall health. Patients should ask which disease-specific team would review their case and whether any highly specialised treatment requires separate assessment or referral.

Breast, lung and prostate cancer programmes draw on diagnostic, surgical and oncology expertise. Decisions may depend on tumour stage, hormone receptors or other biomarkers, and whether treatment aims to cure the disease, reduce recurrence risk or control symptoms. Molecular testing can help guide some systemic treatment choices, but is not equally relevant to every cancer.

Rare cancers also feature in the supplied profile. This is a broad category rather than confirmation that every rare tumour is treated locally. Patients should provide the exact pathology diagnosis and ask about the team's experience with that subtype, specialist pathology review and any appropriate referral elsewhere.

Verfügbare Behandlungen

Surgery can form part of care for suitable cancers, either alone or alongside other treatments. The operation, surgeon's specialty and hospital location depend on the tumour and the wider care pathway. International patients should establish whether an operation would take place at St Bartholomew's or another hospital, and who would manage complications and recovery.

Radiotherapy uses radiation to treat cancer or relieve symptoms. Its suitability depends on the tumour's location, previous radiation exposure and nearby healthy organs. Ask which technique is proposed, whether planning appointments are needed before treatment, and how the schedule affects the required stay in London.

Systemic treatments include chemotherapy, immunotherapy and targeted therapy. These medicines are not interchangeable: the choice depends on the disease, treatment setting, biomarker results and applicable approvals or funding. A medicine available for one cancer may not be appropriate or accessible for another.

Supportive care is relevant throughout treatment, including symptom management and monitoring of treatment effects. Cardio-oncology addresses cardiovascular risks and heart problems associated with cancer care. Patients with existing heart disease or previous potentially cardiotoxic treatment should ask whether specialist cardiac assessment is needed. Participation in a clinical trial may offer another treatment pathway where eligibility and availability align.

Klinische Studien

The supplied profile gives an indicative figure of around 150 active oncology clinical trials. This should not be read as a verified real-time count, or as the number currently accepting international patients. Trial portfolios change, and an active study may be following existing participants rather than recruiting. Research links with Barts Cancer Institute support the centre's broader clinical research environment.

Trial consideration normally requires review by the relevant clinical team, followed by study-specific screening. Eligibility may depend on cancer subtype, molecular findings, previous treatments, organ function and general fitness. Overseas residence can introduce practical requirements concerning funding, repeat visits and ongoing monitoring. Before travelling, request confirmation of a potentially suitable recruiting study, the screening process, required visit schedule and responsibility for costs. Neither referral nor preliminary interest guarantees a trial place or clinical benefit.

Praktische Hinweise für internationale Patientinnen und Patienten

Start by asking the hospital to confirm the appropriate referral route for the exact diagnosis and whether overseas referrals are accepted by that service. A written clinical review or provisional plan can help establish whether travel is justified, although further tests may still change the recommendation. Separate the clinical decision from payment arrangements: eligibility for NHS-funded care is not established simply by attending an NHS hospital, and overseas charging rules may apply.

Plan beyond the first appointment. Clarify treatment locations, accommodation needs, whether a caregiver should accompany you and how urgent problems will be handled outside appointments. Ask your treating clinicians about fitness to travel and safe timing after procedures. Agree how prescriptions, results and follow-up instructions will be shared with your home oncology team.

Kontaktinformationen

Contact details below come from the hospital's own published international patient information.

Location: London, United Kingdom

Email: No public international e-mail address is published; use the website enquiry form.

Phone: +44 20 3416 5000

Website: https://www.bartshealth.nhs.uk

Languages supported: English, Arabic

Remote second opinion: Available

Always confirm current contact details on the hospital's own website before sending medical records, and never send documents to an address you have not verified.

Fragen von Patientinnen und Patienten

Which disease-specific team would review my diagnosis?
Can you assess my records before I travel?
Which tests or pathology reviews would need repeating?
Where would each part of my treatment take place?
What are the treatment aims, alternatives and main risks?
Is there a suitable trial currently recruiting, and can overseas patients participate?
What does the written cost estimate include and exclude?
How will you coordinate follow-up and urgent care with my home team?

Häufige Fragen

How can an international patient obtain a referral?

Contact Barts Health through its official website to confirm the correct pathway for the relevant cancer service or private patient team. Ask whether a referral from your current specialist is required and how to submit records securely. The team may need to review your diagnosis and treatment history before offering an appointment. Do not assume that an enquiry confirms acceptance, treatment eligibility or a trial place; obtain written confirmation before committing to travel.

Which medical records should I prepare?

Prepare a concise clinical summary, pathology reports, recent scans and the actual imaging files where available. Include treatment dates, medicine names and doses, radiotherapy summaries, operation reports, current medicines, allergies and relevant medical conditions. Molecular or genetic test results may also be important. Ask whether pathology slides or tissue samples are needed and how these should be transferred. Confirm translation requirements and the approved secure submission method rather than sending sensitive documents through an unverified channel.

What should I expect regarding costs?

Costs depend on the assessment, treatment plan, medicines, hospital stay and any additional care needed. Request a written, itemised estimate after clinical review, including exclusions and how changes to the plan would be charged. Confirm insurer authorisation or other funding before treatment. NHS overseas visitor rules may apply, while private care has separate payment arrangements. For trials, ask which research-related costs are covered and which routine care, travel or accommodation expenses remain your responsibility.

Is language support available?

Ask the receiving service about professional interpreting before booking an appointment, including availability for your language and whether arrangements differ between NHS and private care. Confirm any charges and how interpreting would work for consent discussions, treatment education and telephone follow-up. Written translation of overseas records may need separate arrangements. For important medical decisions, a professional interpreter is generally preferable to relying solely on relatives, particularly when discussing risks, alternatives or sensitive information.

How should I plan travel and accommodation?

Wait for confirmation of the appointment, likely investigations and expected treatment schedule before finalising travel. Ask which hospital sites you will attend and whether accommodation should allow easy access for frequent visits. Establish whether a companion is advisable and whether treatment could affect mobility or fitness to fly. Check applicable entry requirements and travel insurance exclusions. Allow flexibility for additional tests or complications, and obtain clear instructions about whom to contact if you become unwell while in London.

Quellen

1.Barts Health NHS Trust — hospital and service information— Barts Health NHS Trust
2.Cancer information and clinical trials guidance— National Cancer Institute
3.Oncology information and patient resources— European Society for Medical Oncology
4.Global health and cancer information— World Health Organization

GetOnco AI fragen

Erhalten Sie persönliche Antworten zu „St Bartholomew's Hospital — Barts Cancer Centre, London“ von Ihrem KI-Koordinator für Krebsversorgung.

GetOnco AI liefert Informationen zu Bildungszwecken und ersetzt niemals den Rat Ihres Behandlungsteams.